Open-House Contracts 2025-5 - Aflibercept
AOK Bremen/BremerhavenTED 766959-2025
value not stated1 lot
Thu 4 Nov23:59 in Berlin
371days
Public tenders in Germany
945 open tenders
CountryTenderValueClosesDays left
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Formoterol + Beclometasone (exclusively Dafo. IHP, INH), ATC R03AK08 for the period 01.01.2026 - 31.12.2027
DAK-Gesundheit, HamburgTED 778063-2025
€11 lot, 2 years
Fri 5 Nov12:00 in Berlin
372days
Conclusion of a non-exclusive rebate agreement pursuant to § 130a Abs. 8 SGB V for the active substance Peginterferon beta-1a, ATC L03AB13 for the period 01.01.2026 - 31.12.2027
DAK-Gesundheit, HamburgTED 762539-2025
€11 lot, 2 years
Fri 5 Nov12:00 in Berlin
372days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Buserelin, ATC L02AE01 for the period 01.01.2026 - 31.12.2027
DAK-Gesundheit, HamburgTED 763308-2025
€11 lot, 2 years
Fri 5 Nov12:00 in Berlin
372days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substances Insulin lispro, ATC A10AB04 and A10AD04 for the period 01.01.2026 - 31.12.2027
DAK-Gesundheit, HamburgTED 764522-2025
€11 lot, 2 years
Fri 5 Nov12:00 in Berlin
372days
Conclusion of a non-exclusive discount agreement under § 130a, paragraph 8, SGB V for the active substance Paliperidone (exclusively 3-month depot), ATC N05AX13 for the period 01.01.2026 - 31.12.2027
DAK-Gesundheit, HamburgTED 762978-2025
€11 lot, 2 years
Fri 5 Nov12:00 in Berlin
372days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Teriparatid, ATC H05AA02 for the period 01.02.2026 - 31.01.2027 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 831213-2025
€11 lot, 1 year
Sun 5 Dec12:00 in Berlin
402days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Pasireotide, ATC H01CB05 for the period 01.02.2026 - 31.01.2028
DAK-Gesundheit, HamburgTED 832580-2025
€11 lot, 2 years
Sun 5 Dec12:00 in Berlin
402days
Conclusion of a non-exclusive discount agreement pursuant to § 130a, paragraph 8 of the German Social Security Code (SGB V) for the active substance Follitropin, ATC code G03GA05 for the period from 01.02.2026 to 31.01.2028
DAK-Gesundheit, HamburgTED 829368-2025
€11 lot, 2 years
Sun 5 Dec12:00 in Berlin
402days
Conclusion of framework contract OHV: Structural inspections of structures according to DIN 1076
Ministerium für Verkehr Baden-Württemberg, Abteilung 2, StuttgartTED 830154-2025
value not stated1 lot, 2 years
Fri 10 Dec23:59 in Berlin
407days
Conclusion of non-exclusive discount agreements pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) (Open-House Model)
AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 186318-2026
value not stated9 lots
Sat 1 Jan12:00 in Berlin
429days
Open-House Contracts 2026-1
AOK Bremen/BremerhavenTED 696053-2026
value not stated44 lots
Wed 5 Jan23:59 in Berlin
433days
Conclusion of agreements for the economic supply of finished medicinal products for outpatient care within an Open House model
AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, EschbornTED 72816-2026
value not stated31 lots
Tue 1 Feb12:00 in Berlin
460days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Ciclesonid, ATC R03BA08, for the period 01.04.2026 – 31.03.2027 (plus extension option of 1x12 months)
DAK-Gesundheit, HamburgTED 111527-2026
€11 lot, 1 year
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Lanreotide, ATC H01CB03, for the period 01.04.2026 - 31.03.2027 (including extension option 1x12 months)
DAK-Gesundheit, HamburgTED 115409-2026
€11 lot, 1 year
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to §130a Abs. 8 SGB V for the active substance Dexamethasone (exclusively dosage form IMP), ATC S01BA01, for the period 01.04.2026 - 31.03.2028
DAK-Gesundheit, HamburgTED 115975-2026
€11 lot, 2 years
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the German Social Code Book V (SGB V) for the active substance Galcanezumab, ATC N02CD02, for the period 01.04.2026 – 31.03.2028
DAK-Gesundheit, HamburgTED 114799-2026
€11 lot, 2 years
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to § 130a Abs. 8 SGB V for the active substance Interferon beta-1, ATC L03AB08, for the period 01.04.2026 - 31.03.2028
DAK-Gesundheit, HamburgTED 116153-2026
€11 lot, 2 years
Sat 5 Feb12:00 in Berlin
464days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Beclometasone (excluding DaFo IHP), ATC R03BA01, for the period 01.05.26–30.04.28
DAK-Gesundheit, HamburgTED 183467-2026
€11 lot, 2 years
Sun 5 Mar12:00 in Berlin
493days
Conclusion of a non-exclusive discount agreement pursuant to § 130a para. 8 of the Fifth Book of the German Social Code (SGB V) for the active substance Trientine (exclusively for pharmaceutical form FTA), ATC A16AX12, for the period 01.05.26–30.04.28
DAK-Gesundheit, HamburgTED 188197-2026
€11 lot, 2 years
Sun 5 Mar12:00 in Berlin
493days
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.